Suppr超能文献

新型精神活性物质 5-(2-氨基丙基)吲哚(5-IT)中毒:来自瑞典 STRIDA 项目的一系列病例。

Intoxications of the new psychoactive substance 5-(2-aminopropyl)indole (5-IT): a case series from the Swedish STRIDA project.

机构信息

Swedish Poisons Information Centre , Stockholm , Sweden.

出版信息

Clin Toxicol (Phila). 2014 Jul;52(6):618-24. doi: 10.3109/15563650.2014.920088. Epub 2014 Jun 4.

Abstract

CONTEXT

5-(2-aminopropyl)indole (5-IT) is a new psychoactive substance (NPS; "legal high" or "research chemical") structurally related to indoleamines and substituted phenethylamines and implicated in several fatalities. We describe the clinical characteristics and results of laboratory investigations of 14 analytically confirmed nonfatal cases of 5-IT intoxication within the Swedish STRIDA project.

STUDY DESIGN

Observational case series of consecutive patients with admitted or suspected intake of NPS presenting to hospitals in Sweden in 2012.

PATIENTS AND METHODS

Blood and/or urine samples were collected from intoxicated patients presenting to emergency departments and intensive care units over the country. Analysis of NPS was performed using an LC-MS/MS multi-component method. Clinical data were collected when caregivers consulted the Poisons Information Centre and also retrieved from medical records. The severity of poisoning was graded retrospectively using the Poisoning Severity Score (PSS).

RESULTS

Eleven male and three female patients (age: 21-53 years, median: 27) tested positive for 5-IT in 2012, all cases appearing in April-July. The 5-IT concentration in serum ranged between 0.015 and 0.59 μg/mL (median: 0.22; n = 8) and in urine between 0.005 and 24.7 μg/mL (median: 5.95; n = 12). Five intoxications were indicated to be caused by 5-IT alone, whereas additional psychoactive substances were detected in the other nine cases. Six (43%) of fourteen cases were graded as severe (PSS 3), five (36%) as moderate (PSS 2), and three (21%) as minor (PSS 1) poisonings. In the severe cases, agitation, hallucinations, dilated pupils without light reaction, tachycardia, hypertension, hyperthermia, myoclonus, muscle rigidity, arrhythmias, seizures, rhabdomyolysis, and/or renal failure were noted.

CONCLUSIONS

The results demonstrated that severe clinical toxicity was commonly present in patients with analytically confirmed 5-IT exposure. The clinical features are consistent with a sympathomimetic toxidrome, and some patients also displayed symptoms associated with serotonin toxicity.

摘要

背景

5-(2-氨基丙基)吲哚(5-IT)是一种新的精神活性物质(NPS;“合法兴奋剂”或“研究化学品”),在结构上与吲哚胺和取代的苯乙胺有关,并与几起死亡事件有关。我们描述了瑞典 STRIDA 项目中 14 例经分析确认的 5-IT 中毒非致命病例的临床特征和实验室调查结果。

研究设计

对 2012 年在瑞典医院就诊的疑似或摄入 NPS 的连续患者进行观察性病例系列研究。

患者和方法

从全国各急诊室和重症监护病房中毒患者采集血样和/或尿样。使用 LC-MS/MS 多组分方法分析 NPS。医护人员咨询中毒信息中心时收集临床数据,并从病历中检索。使用中毒严重程度评分(PSS)回顾性评估中毒的严重程度。

结果

2012 年,11 名男性和 3 名女性患者(年龄:21-53 岁,中位数:27 岁)血清 5-IT 检测阳性,所有病例均出现在 4 月至 7 月。血清 5-IT 浓度在 0.015 至 0.59 μg/mL 之间(中位数:0.22;n=8),尿液浓度在 0.005 至 24.7 μg/mL 之间(中位数:5.95;n=12)。5 例中毒被认为仅由 5-IT 引起,而在其他 9 例中检测到其他精神活性物质。14 例中有 6 例(43%)为重度(PSS 3),5 例(36%)为中度(PSS 2),3 例(21%)为轻度(PSS 1)中毒。在重度中毒患者中,出现激越、幻觉、瞳孔散大无对光反应、心动过速、高血压、发热、肌阵挛、肌肉僵硬、心律失常、癫痫发作、横纹肌溶解和/或肾衰竭。

结论

结果表明,经分析确认 5-IT 暴露的患者常出现严重的临床毒性。临床特征与拟交感神经毒性综合征一致,一些患者还表现出与 5-羟色胺毒性相关的症状。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验